These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 22077106

  • 1. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis.
    Sastre J, Mullol J, Valero A, Valiente R, Bilastine Study Group.
    Curr Med Res Opin; 2012 Jan; 28(1):121-30. PubMed ID: 22077106
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, Roger A, Sologuren A, Valiente R, Bilastine International Working Group.
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients.
    Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, van de Heyning P, Loureiro A, Bilastine International Working Group.
    Allergy; 2009 Jan; 64(1):158-65. PubMed ID: 19132976
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
    Zuberbier T, Oanta A, Bogacka E, Medina I, Wesel F, Uhl P, Antépara I, Jáuregui I, Valiente R, Bilastine International Working Group.
    Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
    [Abstract] [Full Text] [Related]

  • 5. A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.
    Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I, international Rupatadine study group.
    Allergy; 2008 Jul; 63(7):924-31. PubMed ID: 18588560
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study.
    Okubo K, Gotoh M, Asako M, Nomura Y, Togawa M, Saito A, Honda T, Ohashi Y.
    Allergol Int; 2017 Jan; 66(1):97-105. PubMed ID: 27421817
    [Abstract] [Full Text] [Related]

  • 7. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M, Melac M, Charpentier JC, Didier A.
    Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
    [Abstract] [Full Text] [Related]

  • 8. Long-term safety and efficacy of bilastine following up to 12 weeks or 52 weeks of treatment in Japanese patients with allergic rhinitis: Results of an open-label trial.
    Okubo K, Gotoh M, Togawa M, Saito A, Ohashi Y.
    Auris Nasus Larynx; 2017 Jun; 44(3):294-301. PubMed ID: 27561709
    [Abstract] [Full Text] [Related]

  • 9. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.
    Singh-Franco D, Ghin HL, Robles GI, Borja-Hart N, Perez A.
    Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of cetirizine and terfenadine versus placebo in the symptomatic management of seasonal allergic rhinitis.
    Lockey RF, Widlitz MD, Mitchell DQ, Lumry W, Dockhorn R, Woehler T, Grossman J.
    Ann Allergy Asthma Immunol; 1996 May; 76(5):448-54. PubMed ID: 8630719
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study.
    Hide M, Yagami A, Togawa M, Saito A, Furue M.
    Allergol Int; 2017 Apr; 66(2):317-325. PubMed ID: 27599913
    [Abstract] [Full Text] [Related]

  • 12. Effect of cetirizine on symptom severity and quality of life in perennial allergic rhinitis.
    Skoner DP, LaForce CF, Nathan RA, Urdaneta ER, Zielinski MA, Sacavage SD, Franklin KB, Wu MM.
    Allergy Asthma Proc; 2014 Apr; 35(4):338-45. PubMed ID: 24992553
    [Abstract] [Full Text] [Related]

  • 13. Bilastine: in allergic rhinitis and urticaria.
    Carter NJ.
    Drugs; 2012 Jun 18; 72(9):1257-69. PubMed ID: 22686617
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
    Corren J, Storms W, Bernstein J, Berger W, Nayak A, Sacks H, Azelastine Cetirizine Trial No. 1 (ACT 1) Study Group.
    Clin Ther; 2005 May 18; 27(5):543-53. PubMed ID: 15978303
    [Abstract] [Full Text] [Related]

  • 15. Establishing the place in therapy of bilastine in the treatment of allergic rhinitis according to ARIA: evidence review.
    Bousquet J, Ansótegui I, Canonica GW, Zuberbier T, Baena-Cagnani CE, Bachert C, Cruz AA, González SN, Kuna P, Morais-Almeida M, Mullol J, Ryan DP, Sánchez-Borges M, Valiente R, Church MK.
    Curr Med Res Opin; 2012 Jan 18; 28(1):131-9. PubMed ID: 22149770
    [Abstract] [Full Text] [Related]

  • 16. Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis.
    Horak F, Stübner P, Zieglmayer R, Kavina A, Corrado ME, Assandri A, Mion A.
    Arzneimittelforschung; 2004 Jan 18; 54(10):666-72. PubMed ID: 15553106
    [Abstract] [Full Text] [Related]

  • 17. Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study.
    Potter P, Maspero JF, Vermeulen J, Barkai L, Németh I, Baillieau RA, Garde JM, Giralt J, Doménech A, Izquierdo I, Nieto A.
    Pediatr Allergy Immunol; 2013 Mar 18; 24(2):144-50. PubMed ID: 23384091
    [Abstract] [Full Text] [Related]

  • 18. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit.
    Day JH, Briscoe M, Widlitz MD.
    J Allergy Clin Immunol; 1998 May 18; 101(5):638-45. PubMed ID: 9600501
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
    Jacobs R, Martin B, Hampel F, Toler W, Ellsworth A, Philpot E.
    Curr Med Res Opin; 2009 Jun 18; 25(6):1393-401. PubMed ID: 19419338
    [Abstract] [Full Text] [Related]

  • 20. Safety profile of bilastine: 2nd generation H1-antihistamines.
    Scaglione F.
    Eur Rev Med Pharmacol Sci; 2012 Dec 18; 16(14):1999-2005. PubMed ID: 23242729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.